Bridgeway Capital Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-263,243
| Closed | -$1.93M | – | 1256 |
|
|
2024
Q4 | $1.93M | Sell |
263,243
-66,538
| -20% | -$488K | 0.04% | 525 |
|
|
2024
Q3 | $2.47M | Sell |
329,781
-458,923
| -58% | -$3.44M | 0.05% | 479 |
|
|
2024
Q2 | $7.02M | Sell |
788,704
-480,040
| -38% | -$4.27M | 0.16% | 180 |
|
|
2024
Q1 | $12.9M | Sell |
1,268,744
-75,160
| -6% | -$761K | 0.26% | 103 |
|
|
2023
Q4 | $13.5M | Sell |
1,343,904
-1,731
| -0.1% | -$17.4K | 0.29% | 70 |
|
|
2023
Q3 | $12.6M | Buy |
+1,345,635
| New | +$12.6M | 0.31% | 59 |
|